🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInsurance & AccessGoodRx vs manufacturer copay cards — which saves more?

GoodRx vs manufacturer copay cards — which saves more?

PharmHunterJen Mon, Jun 1, 2026 at 3:39 AM 12 replies 291 viewsPage 1 of 3
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Jun 1, 2026 at 3:39 AM#1

Collecting this in one place because it comes up every few weeks and the answer is always assembled from scratch. It is about cost and coverage, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

Denials are usually procedural rather than clinical, and the order that works reflects that. Get the denial reason in writing, because it names the criterion you failed. Then supply the documentation that criterion asks for — usually documented BMI with a comorbidity, or a failed prior therapy. Then appeal, and ask for a peer-to-peer review, because a prescriber talking to a reviewing clinician resolves a large fraction of denials that written appeals do not. Manufacturer copay assistance is separate and applies mainly to commercial insurance, and patient assistance programmes are means-tested rather than a discount.

The condition it depends on

Coverage criteria are plan-specific rather than insurer-specific. Two people with the same insurer and different employers have different rules, which is why "my insurer covers it" is not transferable information.

What I am not sure about

What I actually want to know is what actually works on a prior-authorisation denial, as opposed to the list of things that sound like they should work. Tell me what I have not thought of.

— PharmHunterJen · corrections welcome and will be edited into this post with credit
25 20Dr.LipidDallas, alex_tucson, kevin_tulsa and 22 others
Reply Quote Save Share Report
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Jun 1, 2026 at 3:56 AM#2
PharmHunterJen said:
Denials are usually procedural rather than clinical, and the order that works reflects that.

Financial impact of cost and coverage weight loss beyond medication cost:

  • Groceries: SAVED $272/month (eating less)
  • Restaurants: SAVED $182/month (fewer meals out)
  • Alcohol: SAVED $132/month (stopped drinking)
  • Life insurance: Premium REDUCED by $42/month (lower BMI)
  • Copays: SAVED $52/month (fewer BP/cholesterol meds)

Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.

24 19wei_SG, cory_ATX, lori_vegas and 21 others
Reply Quote Save Share Report
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Jun 1, 2026 at 4:12 AM#3
PharmHunterJen said:
Denials are usually procedural rather than clinical, and the order that works reflects that.

I read this differently from PharmHunterJen, on substance rather than tone. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

23 18CanadaChris, ZaraB_AL, JakeSmashed95 and 20 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Jun 1, 2026 at 4:29 AM#4
amsterdam_pete said:
The affordability discussion here usually stops at individual tactics.

Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives:

  1. Prior authorization appeal with peer-to-peer review
  2. Manufacturer copay card (for commercial insurance)
  3. Patient assistance programs (Novo Nordisk, Eli Lilly)
  4. Compounded medication from a 503B pharmacy ($106/month)
  5. Canadian pharmacy (requires prescription, ~40-60% savings)

Don't let cost prevent access to effective treatment. There are options at every price point.

22 17dan_philly, MeganSA_TX, LarryQC_SD and 19 others
Reply Quote Save Share Report
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Jun 1, 2026 at 6:01 AM#5
Dr.LipidDallas said:
Financial impact of cost and coverage weight loss beyond medication cost: Groceries: SAVED $272/month (eating less) Restaurants: SAVED $182/month…

Adding a me-too, because a thread of one person's experience is not much use.

Last edited: Jun 1, 2026 at 8:01 AM
21 16ben_calgary, patPC_UT, Dr.DermMIA and 18 others
Reply Quote Save Share Report

Similar Threads

Prior authorization success: step-by-step guide with templates5 replies
Cigna now covering Zepbound — how I got approved13 replies
Appeal letter template — denied PA for GLP-1 medications4 replies
Mounjaro savings card — manufacturer program changes 202610 replies
Medicare Part D GLP-1 coverage — what's covered in 202610 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register